TY - JOUR
T1 - Exploring the links between systemic lupus erythematosus and cancer
AU - Bernatsky, Sasha
AU - Ramsey-Goldman, Rosalind
AU - Clarke, Ann
PY - 2005/5
Y1 - 2005/5
N2 - Recent data confirm that certain cancers, particularly hematologic, occur more frequently in SLE than in the general population. Numerous pathogenic mechanisms are possible, but hypotheses remain largely speculative. In particular, data are inadequate on how cancer risk in SLE may be related to medication exposures. To evaluate the impact of medication exposures on cancer risk in SLE, cooperative efforts of SLICC and CaNIOS are currently in progress. This should provide much-needed insight into the pathogenesis of the association between cancer and SLE.
AB - Recent data confirm that certain cancers, particularly hematologic, occur more frequently in SLE than in the general population. Numerous pathogenic mechanisms are possible, but hypotheses remain largely speculative. In particular, data are inadequate on how cancer risk in SLE may be related to medication exposures. To evaluate the impact of medication exposures on cancer risk in SLE, cooperative efforts of SLICC and CaNIOS are currently in progress. This should provide much-needed insight into the pathogenesis of the association between cancer and SLE.
UR - http://www.scopus.com/inward/record.url?scp=19544378505&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=19544378505&partnerID=8YFLogxK
U2 - 10.1016/j.rdc.2005.01.002
DO - 10.1016/j.rdc.2005.01.002
M3 - Review article
C2 - 15922152
AN - SCOPUS:19544378505
SN - 0889-857X
VL - 31
SP - 387
EP - 402
JO - Rheumatic Disease Clinics of North America
JF - Rheumatic Disease Clinics of North America
IS - 2
ER -
